N-myc downstream-regulated gene 1: Diverse and complicated functions in human hepatocellular carcinoma (Review)
- PMID: 24260043
- PMCID: PMC3834550
- DOI: 10.3892/ol.2013.1636
N-myc downstream-regulated gene 1: Diverse and complicated functions in human hepatocellular carcinoma (Review)
Abstract
N-myc downstream-regulated gene 1 (NDRG1) has been reported to be a multifunctional protein associated with carcinogenesis and tumor progression. However, the cellular function of NDRG1 remains elusive in human hepatocellular carcinoma (HCC). No NDRG1 expression is observed in normal liver tissue. Overexpression of NDRG1 has been observed in human HCC, particularly with aggressive invasion, metastasis, poor differentiation and short patient survival. In addition, recent studies have shown that NDRG1 exhibits an inhibitory effect on HCC growth in vitro and in vivo, which contrasts with previous reports indicating that NDRG1 promotes the proliferation and invasion of HCC cell lines. Further studies have shown that the localization of NDRG1 is variable, translocating to the nucleus or membrane according to the cell state, which may relate to the diverse function of NDRG1. The present study reviews our current knowledge with regard to the functions of NDRG1 in HCC and other types of human cancer.
Keywords: DNA damage; N-myc downstream regulated gene-1; differentiation; hepatocellular carcinoma; localization; metastasis.
Similar articles
-
N-myc downstream-regulated gene 1 inhibits the proliferation and invasion of hepatocellular carcinoma cells via the regulation of integrin β3.Oncol Lett. 2017 May;13(5):3599-3607. doi: 10.3892/ol.2017.5924. Epub 2017 Mar 27. Oncol Lett. 2017. PMID: 28521460 Free PMC article.
-
N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma.Oncol Rep. 2008 Dec;20(6):1329-35. Oncol Rep. 2008. PMID: 19020710
-
NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24. Cancer Lett. 2011. PMID: 21763068
-
Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy.Biochim Biophys Acta. 2014 Jan;1845(1):1-19. doi: 10.1016/j.bbcan.2013.11.002. Epub 2013 Nov 21. Biochim Biophys Acta. 2014. PMID: 24269900 Review.
-
Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer.Free Radic Biol Med. 2020 Sep;157:154-175. doi: 10.1016/j.freeradbiomed.2019.05.020. Epub 2019 May 24. Free Radic Biol Med. 2020. PMID: 31132412 Review.
Cited by
-
N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.J Virol. 2018 Jan 2;92(2):e01166-17. doi: 10.1128/JVI.01166-17. Print 2018 Jan 15. J Virol. 2018. PMID: 29118118 Free PMC article.
-
Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer.Front Oncol. 2021 Jul 9;11:681717. doi: 10.3389/fonc.2021.681717. eCollection 2021. Front Oncol. 2021. PMID: 34307149 Free PMC article.
-
NDRG1 facilitates lytic replication of Kaposi's sarcoma-associated herpesvirus by maintaining the stability of the KSHV helicase.PLoS Pathog. 2021 Jun 2;17(6):e1009645. doi: 10.1371/journal.ppat.1009645. eCollection 2021 Jun. PLoS Pathog. 2021. PMID: 34077484 Free PMC article.
-
A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma.Curr Med Sci. 2018 Aug;38(4):590-596. doi: 10.1007/s11596-018-1918-x. Epub 2018 Aug 20. Curr Med Sci. 2018. PMID: 30128866
-
NDRG1 facilitates the replication and persistence of Kaposi's sarcoma-associated herpesvirus by interacting with the DNA polymerase clamp PCNA.PLoS Pathog. 2019 Feb 27;15(2):e1007628. doi: 10.1371/journal.ppat.1007628. eCollection 2019 Feb. PLoS Pathog. 2019. PMID: 30811506 Free PMC article.
References
-
- Bruix J, Llovet JM. Major achievements in hepatocellular carcinoma. Lancet. 2009;373:614–616. - PubMed
-
- Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010;30:61–74. - PubMed
-
- Llovet JM, Fuster J, Bruix J Barcelona-Clínic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10(2 Suppl 1):S115–S120. - PubMed
-
- Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol. 2002;81:195–202. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases